![Jessie English](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jessie English
Keine laufenden Positionen mehr
Profil
Former jobs of Jessie M.
English include being a Senior Director at IRBM SpA and Merck Research Laboratories Massachusetts LLC from 2008 to 2010.
Dr. English also served as an Independent Director at Sensei Biotherapeutics, Inc. from 2021 to 2024 and as the Chief Scientific Officer at Tilos Therapeutics, Inc. from 2018 to 2019.
Additionally, Dr. English held the position of Head-Research at Belfer Center for Applied Cancer Science.
Other former positions include Vice President-Kinase Biology at ArQule, Inc. from 2010 to 2011 and VP & Head-Discovery Research at EMD Serono, Inc. from 2016 to 2018.
Furthermore, Dr. English served as the Chief Scientific Officer at Bakx Therapeutics, Inc. from 2020 to 2022.
Education history of Dr. English includes an undergraduate degree from Kansas State University and a doctorate degree from The University of North Carolina at Chapel Hill.
Ehemalige bekannte Positionen von Jessie English
| Unternehmen | Position | Ende |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.07.2024 |
Bakx Therapeutics, Inc.
 Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer therapeutics | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2022 |
Tilos Therapeutics, Inc.
 Tilos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for cancer, fibrosis and autoimmune disease | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2019 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Corporate Officer/Principal | 01.01.2018 |
| ARQULE, INC. | Corporate Officer/Principal | 01.01.2011 |
Ausbildung von Jessie English
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
27
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Kansas State University
 Kansas State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Chapel Hill
 The University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
IRBM SpA
 IRBM SpA BiotechnologyHealth Technology Researches and develops new drugs | Health Technology |
Tilos Therapeutics, Inc.
Tilos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics for cancer, fibrosis and autoimmune disease | Health Technology |
Belfer Center for Applied Cancer Science
 Belfer Center for Applied Cancer Science Miscellaneous Commercial ServicesCommercial Services Operates cancer research center | Commercial Services |
Sensei Biotherapeutics, Inc.
 Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Bakx Therapeutics, Inc.
Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer therapeutics | Health Technology |
